Trimethobenzamide Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Trimethobenzamide Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

TRIMETHOBENZAMIDE HYDROCHLORIDE DESCRIPTION


Trimethobenzamide Hydrochloride




CLINICAL PHARMACOLOGY

Mechanism of Action


PHARMACOKINETICS



USE IN SPECIFIC POPULATIONS

Age
PRECAUTIONS: GeneralDOSAGE AND ADMINISTRATION

Gender


Race


Renal Impairment
PRECAUTIONS: GeneralDOSAGE AND ADMINISTRATION

INDICATIONS & USAGE



TRIMETHOBENZAMIDE HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS











PRECAUTIONS




General

CLINICAL PHARMACOLOGYDOSAGE AND ADMINISTRATION

GERIATRIC USE


CLINICAL PHARMACOLOGYDOSAGE AND ADMINISTRATION

TRIMETHOBENZAMIDE HYDROCHLORIDE ADVERSE REACTIONS



DOSAGE & ADMINISTRATION

WARNINGSPRECAUTIONS


Geriatric Patients
CLINICAL PHARMACOLOGYPRECAUTIONS

Patients with Renal Impairment
CLINICAL PHARMACOLOGYPRECAUTIONS




HOW SUPPLIED





STORAGE AND HANDLING





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Trimethobenzamide Hydrochloride

Trimethobenzamide Hydrochloride

Trimethobenzamide Hydrochloride

Trimethobenzamide Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-496(NDC:53489-376)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOBENZAMIDE 300 mg

Inactive Ingredients

Ingredient Name Strength
ferric oxide red
GELATIN
MAGNESIUM STEARATE
cellulose, microcrystalline
titanium dioxide
D&C YELLOW NO. 10
ALUMINUM OXIDE
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FERROSOFERRIC OXIDE
propylene glycol
SHELLAC
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
brown 18 mm MUTUAL;401 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-496-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076570 2011-08-18


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.